Valuation: The ACME Laboratories Ltd.

Market Cap 17.44B 142M 122M 114M 104M 196M 13.52B 198M 1.34B 523M 6.82B 533M 521M 22.6B P/E 2024
5.9x
P/E 2025 6.29x
Enterprise Value 40.31B 328M 281M 263M 241M 454M 31.27B 458M 3.11B 1.21B 15.77B 1.23B 1.2B 52.24B EV / Sales 2024
1.15x
EV / Sales 2025 1.06x
Free-Float
51.84%
Yield 2024
5.11%
Yield 2025 4.85%
1 week-2.92%
Current month-4.67%
1 month-3.74%
3 months+4.18%
6 months-0.62%
Current year+12.41%
1 week 79.2
Extreme 79.2
81.6
1 month 79.2
Extreme 79.2
84.9
Current year 70.6
Extreme 70.6
88.7
1 year 68.6
Extreme 68.6
88.7
3 years 62.6
Extreme 62.6
94.5
5 years 62.6
Extreme 62.6
117.7
10 years 54.2
Extreme 54.2
122.4
Manager TitleAgeSince
Chief Executive Officer 82 1995-09-29
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 82 1975-03-16
Director/Board Member 76 1981-04-14
Chairman 69 2018-09-04
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.92%-2.92%-6.24% 137M
-1.08%+0.63%+77.40%+122.79% 1,111B
+0.53%+0.76%+53.11%+64.31% 658B
+0.47%+2.64%+28.05%+81.17% 467B
+0.92%+4.97%+42.94%+43.69% 369B
+1.25%+4.00%+25.87%+42.82% 301B
+3.02%+7.92%+4.24%+16.06% 256B
-0.36%+3.98%+53.29%+72.48% 240B
+2.86%+5.27%-15.42%-52.34% 207B
+1.38%+3.72%+30.33%+93.56% 182B
Average +0.93%+3.90%+29.69%+47.83% 379.11B
Weighted average by Cap. +0.56%+4.68%+45.87%+72.12%

Financials

2024 2025
Net sales 31.93B 260M 223M 209M 191M 360M 24.77B 363M 2.46B 958M 12.5B 975M 954M 41.38B 35.94B 292M 251M 235M 214M 405M 27.87B 409M 2.77B 1.08B 14.06B 1.1B 1.07B 46.57B
Net income 2.46B 19.98M 17.12M 16.05M 14.66M 27.66M 1.91B 27.93M 189M 73.68M 961M 75.03M 73.4M 3.18B 2.43B 19.76M 16.93M 15.87M 14.49M 27.35M 1.88B 27.62M 187M 72.85M 950M 74.19M 72.58M 3.15B
Net Debt 22.18B 180M 155M 145M 132M 250M 17.2B 252M 1.71B 665M 8.68B 678M 663M 28.74B 22.87B 186M 159M 149M 136M 258M 17.74B 260M 1.76B 686M 8.95B 699M 684M 29.64B
Logo The ACME Laboratories Ltd.
The ACME Laboratories Limited is a Bangladesh-based company, which is engaged in manufacturing, marketing, and distribution of pharmaceuticals formulation products. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products, which include human drugs comprising dosages like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, and sachet products. It also offers veterinary drugs comprising dosages like bolus, liquid, injection, water-soluble powder, premix, and herbal drugs comprising dosages like liquid, capsule, tablet, cream, and ointment. The products of the Company are sold in domestic and international markets, respectively. Its factory is situated at Dhulivita, Dhamrai, Dhaka, and Bangladesh. It produces approximately 800 products in different dosage forms.
Employees
9,025
Date Price Change Volume
26-08-24 BDT 79.70 0.00% 104,665
26-08-24 BDT 79.70 -0.87% 182,530
26-08-23 BDT 80.40 -0.86% 126,889
26-08-20 BDT 81.10 +0.25% 89,774
26-08-19 BDT 80.90 +0.50% 137,088
  1. Stock Market
  2. Stocks
  3. ACMELAB Stock